{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,23]],"date-time":"2026-06-23T16:15:35Z","timestamp":1782231335715,"version":"3.54.5"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,6,5]],"date-time":"2020-06-05T00:00:00Z","timestamp":1591315200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,6,5]],"date-time":"2020-06-05T00:00:00Z","timestamp":1591315200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Science Foundation of China","doi-asserted-by":"crossref","award":["81471477"],"award-info":[{"award-number":["81471477"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cardiovasc Disord"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n<jats:title>Background<\/jats:title>\n<jats:p>Peripartum cardiomyopathy (PPCM) is life-threatening heart disease. However, the causes and pathogenesis of PPCM remain unclear. Previous studies found that \u03b21 adrenoceptor antibodies (\u03b21AA) had possible involvement in the development of PPCM. In the present study, we determined the potential relationship between PPCM and \u03b21AA, including the mechanism of \u03b21AA leading to PPCM.<\/jats:p>\n<\/jats:sec><jats:sec>\n<jats:title>Methods<\/jats:title>\n<jats:p>We extracted the \u03b21AA from the postpartum Wistar rats that were injected by the antigen peptide segment of the \u03b21 adrenoceptor to produce PPCM. We tested the effects of \u03b21AA on H9C2 cell line by CCK-8, LDH, TUNEL, SA-ELISA, qRT-PCR, and western blot methods. Furthermore, PGC-1\u03b1 was overexpressed to rescue the effect of \u03b21AA on H9C2 cells.<\/jats:p>\n<\/jats:sec><jats:sec>\n<jats:title>Results<\/jats:title>\n<jats:p>We found that the extracted \u03b21AA induced apoptosis of cardiac myocytes of H9C2 cell line. Moreover, the expression of peroxisome proliferator-activated receptor \u03b3 coactivator-1\u03b1 (PGC-1\u03b1), which is a master regulator of mitochondrial metabolism, and its downstream transcript vascular endothelial growth factor (VEGF) got decreased in H9C2 cells after \u03b21AA treatment. In addition, the effect of \u03b21AA could be inhibited by atenolol, the antagonist of \u03b21 adrenoceptors (\u03b21AR) and imitated by isoprenaline, the agonist of \u03b21AR. Furthermore, overexpression of PGC-1\u03b1 in the H9C2 cells rescued the apoptosis of cells and inhibitory expression of VEGF induced by \u03b21AA.<\/jats:p>\n<\/jats:sec><jats:sec>\n<jats:title>Conclusions<\/jats:title>\n<jats:p>Our results suggest that the symptoms of PPCM due to myocardial cell apoptosis induced by \u03b21AA inhibiting the PGC-1\u03b1-related pathway impairs mitochondrial energy metabolism. Therefore, our results uncover a previously unknown role of the \u03b21AA pathway in the etiology of PPCM and provide a novel potential target for the treatment of PPCM.<\/jats:p>\n<\/jats:sec>","DOI":"10.1186\/s12872-020-01492-3","type":"journal-article","created":{"date-parts":[[2020,6,5]],"date-time":"2020-06-05T12:02:43Z","timestamp":1591358563000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["\u03b21 adrenoceptor antibodies induce myocardial apoptosis via inhibiting PGC-1\u03b1-related pathway"],"prefix":"10.1186","volume":"20","author":[{"given":"Linying","family":"Shi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jia","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mulei","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2241-3116","authenticated-orcid":false,"given":"Jiamei","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,6,5]]},"reference":[{"key":"1492_CR1","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1111\/eci.12598","volume":"46","author":"A Najafi","year":"2016","unstructured":"Najafi A, Sequeira V, Kuster DW, van der Velden J. \u03b2-adrenergic receptor signalling and its functional consequences in the diseased heart. Eur J Clin Invest. 2016;46:362\u201374.","journal-title":"Eur J Clin Invest"},{"key":"1492_CR2","doi-asserted-by":"publisher","first-page":"1397","DOI":"10.1161\/CIRCULATIONAHA.115.020491","volume":"133","author":"Z Arany","year":"2016","unstructured":"Arany Z, Elkayam U. Peripartum cardiomyopathy. Circulation. 2016;133:1397\u2013409.","journal-title":"Circulation"},{"key":"1492_CR3","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0086770","volume":"9","author":"J Liu","year":"2014","unstructured":"Liu J, Wang Y, Chen M, Zhao W, Wang X, Wang H, Zhang Z, Zhang J, Xu L, Chen J, Yang X, Zhang L. The correlation between peripartum cardiomyopathy and autoantibodies against cardiovascular receptors. PLoS One. 2014;9:e86770.","journal-title":"PLoS One"},{"key":"1492_CR4","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1136\/heartjnl-2019-315060","volume":"105","author":"L Baris","year":"2019","unstructured":"Baris L, Cornette J, Johnson MR, Sliwa K, Roos-Hesselink JW. Peripartum cardiomyopathy: disease or syndrome? Heart. 2019;105:357\u201362.","journal-title":"Heart"},{"key":"1492_CR5","doi-asserted-by":"publisher","first-page":"2540","DOI":"10.1161\/CIRCULATIONAHA.107.670588","volume":"115","author":"BN Finck","year":"2007","unstructured":"Finck BN, Kelly DP. Peroxisome proliferator-activated receptor gamma coactivator-1 (PGC-1) regulatory cascade in cardiac physiology and disease. Circulation. 2007;115:2540\u20138.","journal-title":"Circulation"},{"key":"1492_CR6","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1172\/JCI27794","volume":"116","author":"BN Finck","year":"2006","unstructured":"Finck BN, Kelly DP. PGC-1 coactivators: inducible regulators of energy metabolism in health and disease. J Clin Invest. 2006;116:615\u201322.","journal-title":"J Clin Invest"},{"key":"1492_CR7","doi-asserted-by":"publisher","first-page":"1960","DOI":"10.1161\/RES.0000000000000104","volume":"118","author":"E Murphy","year":"2016","unstructured":"Murphy E, Ardehali H, Balaban RS, DiLisa F, Dorn GW 2nd, Kitsis RN, Otsu K, Ping P, Rizzuto R, Sack MN, Wallace D, Youle RJ. American Heart Association Council on Basic Cardiovascular Sciences, Council on Clinical Cardiology, and Council on Functional Genomics and Translational Biology. Mitochondrial Function, Biology, and Role in Disease: A Scientific Statement From the American Heart Association. Circ Res. 2016;118:1960\u201391.","journal-title":"Circ Res"},{"key":"1492_CR8","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/S0014-2999(03)01431-6","volume":"466","author":"Y Staudt","year":"2003","unstructured":"Staudt Y, Mobini R, Fu M, Felix SB, K\u00fchn JP, Staudt A. Beta1-adrenoceptor antibodies induce apoptosis in adult isolated cardiomyocytes. Eur J Pharmacol. 2003;466:1\u20136.","journal-title":"Eur J Pharmacol"},{"key":"1492_CR9","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1172\/JCI24405","volume":"115","author":"JM Huss","year":"2005","unstructured":"Huss JM, Kelly DP. Mitochondrial energy metabolism in heart failure: a question of balance. J Clin Invest. 2005;115:547\u201355.","journal-title":"J Clin Invest"},{"key":"1492_CR10","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1016\/j.molcel.2011.08.044","volume":"44","author":"N Sen","year":"2011","unstructured":"Sen N, Satija YK, Das S. PGC-1\u03b1, a key modulator of p53, promotes cell survival upon metabolic stress. Mol Cell. 2011;44:621\u201334.","journal-title":"Mol Cell"},{"key":"1492_CR11","doi-asserted-by":"publisher","first-page":"e482","DOI":"10.1111\/jpn.12706","volume":"102","author":"N Khodambashi Emami","year":"2018","unstructured":"Khodambashi Emami N, Golian A, Danesh Mesgaran M, Anthony NB, Rhoads DD. Mitochondrial biogenesis and PGC-1\u03b1 gene expression in male broilers from ascites-susceptible and -resistant lines. J Anim Physiol Anim Nutr (Berl). 2018;102:e482\u20135.","journal-title":"J Anim Physiol Anim Nutr (Berl)"},{"key":"1492_CR12","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1016\/S0092-8674(00)80611-X","volume":"98","author":"Z Wu","year":"1999","unstructured":"Wu Z, Puigserver P, Andersson U, Zhang C, Adelmant G, Mootha V, Troy A, Cinti S, Lowell B, Scarpulla RC, Spiegelman BM. Mechanisms controlling mitochondrial biogenesis and respiration through the thermogenic coactivator PGC-1. Cell. 1999;98:115\u201324.","journal-title":"Cell."},{"key":"1492_CR13","volume":"3","author":"D Kolte","year":"2014","unstructured":"Kolte D, Khera S, Aronow WS, Palaniswamy C, Mujib M, Ahn C, Jain D, Gass A, Ahmed A, Panza JA, Fonarow GC. Temporal trends in incidence and outcomes of Peripartum cardiomyopathy in the United States: a Nationwide population-based study. J Am Heart Assoc. 2014;3:e001056.","journal-title":"J Am Heart Assoc"},{"key":"1492_CR14","doi-asserted-by":"publisher","first-page":"1602","DOI":"10.4065\/80.12.1602","volume":"80","author":"JD Fett","year":"2005","unstructured":"Fett JD, Christie LG, Carraway RD, Murphy JG. Five-year prospective study of the incidence and prognosis of peripartum cardiomyopathy at a single institution. Mayo Clin Proc. 2005;80:1602\u20136.","journal-title":"Mayo Clin Proc"},{"key":"1492_CR15","first-page":"228","volume":"17","author":"SA Isezuo","year":"2007","unstructured":"Isezuo SA, Abubakar SA. Epidemiologic profile of peripartum cardiomyopathy in a tertiary care hospital. Ethn Dis. 2007;17:228\u201333.","journal-title":"Ethn Dis"},{"key":"1492_CR16","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1016\/j.ijgo.2006.05.009","volume":"94","author":"JD Fett","year":"2006","unstructured":"Fett JD, Murphy JG. Infant survival in Haiti after maternal death from peripartum cardiomyopathy. Int J Gynaecol Obstet. 2006;94:135\u20136.","journal-title":"Int J Gynaecol Obstet"},{"key":"1492_CR17","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1161\/01.RES.64.1.97","volume":"1","author":"CJ Limas","year":"1989","unstructured":"Limas CJ, Goldenberg IF, Limas C. Autoantibodies against betaadrenoceptors in human idiopathic dilated cardiomyopathy. Circ Res. 1989;1:97\u2013103.","journal-title":"Circ Res"},{"key":"1492_CR18","doi-asserted-by":"publisher","first-page":"1658","DOI":"10.1172\/JCI114888","volume":"5","author":"Y Magnusson","year":"1990","unstructured":"Magnusson Y, Marullo S, Hoyer S, Waagstein F, Andersson B, Vahlne A, Guillet JG, Strosberg AD, Hjalmarson A, Hoebeke J. Mapping of a functional autoimmune epitope on the beta 1-adrenergic receptor in patients with idiopathic dilated cardiomyopathy. J Clin Invest. 1990;5:1658\u201363.","journal-title":"J Clin Invest"},{"key":"1492_CR19","doi-asserted-by":"publisher","first-page":"578","DOI":"10.1161\/01.RES.88.6.578","volume":"6","author":"M Iwata","year":"2001","unstructured":"Iwata M, Yoshikawa T, Baba A, Anzai T, Nakamura I, Wainai Y, Takahashi T, Ogawa S. Autoimmunity against the second extracellular loop of beta(1)-adrenergic receptors induces beta-adrenergic receptor desensitization and myocardial hypertrophy in vivo. Circ Res. 2001;6:578\u201386.","journal-title":"Circ Res"},{"key":"1492_CR20","doi-asserted-by":"crossref","unstructured":"Liu HR, Zhao RR, Jiao XY, Wang YY, Fu M. Relationship of myocardial remodeling to the genesis of serum autoantibodies to cardiac beta(1)-adrenoceptors and muscarinic type 2 acetylcholine receptors in rats. J Am Coll Cardiol. 2002;11:1866\u201373.","DOI":"10.1016\/S0735-1097(02)01865-X"},{"issue":"10","key":"1492_CR21","doi-asserted-by":"publisher","first-page":"1176","DOI":"10.1161\/CIRCRESAHA.111.245092","volume":"109","author":"MR Bristow","year":"2011","unstructured":"Bristow MR. Treatment of chronic heart failure with \u03b2-adrenergic receptor antagonists: a convergence of receptor pharmacology and clinical cardiology. Circ Res. 2011;109(10):1176\u201394.","journal-title":"Circ Res"},{"key":"1492_CR22","doi-asserted-by":"crossref","unstructured":"Grisanti LA, de Lucia C, Thomas TP, Stark A, Strony JT, Myers VD, Beretta R, Yu D, Sardu C, Marfella R, Gao E, Houser SR, Koch WJ, Hamad EA, Tilley DG. Prior \u03b2-blocker treatment decreases leukocyte responsiveness to injury. JCI Insight. 2019;5:e99485.","DOI":"10.1172\/jci.insight.99485"},{"key":"1492_CR23","doi-asserted-by":"publisher","first-page":"1030","DOI":"10.3389\/fphys.2018.01030","volume":"9","author":"C Sardu","year":"2018","unstructured":"Sardu C, Pieretti G, D'Onofrio N, Ciccarelli F, Paolisso P, Passavanti MB, Marfella R, Cioffi M, Mone P, Dalise AM, Ferraraccio F, Panarese I, Gambardella A, Passariello N, Rizzo MR, Balestrieri ML, Nicoletti G, Barbieri M. Inflammatory cytokines and SIRT1 levels in subcutaneous abdominal fat: relationship with cardiac performance in overweight pre-diabetics patients. Front Physiol. 2018;9:1030.","journal-title":"Front Physiol"},{"key":"1492_CR24","doi-asserted-by":"crossref","unstructured":"D'Onofrio N, Pieretti G, Ciccarelli F, Gambardella A, Passariello N, Rizzo MR, Barbieri M, Marfella R, Nicoletti G, Balestrieri ML, Sardu C. Abdominal Fat SIRT6 Expression and Its Relationship with Inflammatory and Metabolic Pathways in Pre-Diabetic Overweight Patients. Int J Mol Sci. 2019;20.","DOI":"10.3390\/ijms20051153"},{"issue":"10","key":"1492_CR25","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13098-017-0304-3","volume":"3","author":"R Marfella","year":"2018","unstructured":"Marfella R, Sardu C, Balestrieri ML, Siniscalchi M, Minicucci F, Signoriello G, Calabr\u00f2 P, Mauro C, Pieretti G, Coppola A, Nicoletti G, Rizzo MR, Paolisso G, Barbieri M. Effects of incretin treatment on cardiovascular outcomes in diabetic STEMI-patients with culprit obstructive and multivessel non obstructive-coronary-stenosis. Diabetol Metab Syndr. 2018;3(10):1.","journal-title":"Diabetol Metab Syndr"},{"key":"1492_CR26","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1111\/dom.13122","volume":"20","author":"R Marfella","year":"2018","unstructured":"Marfella R, Sardu C, Calabr\u00f2 P, Siniscalchi M, Minicucci F, Signoriello G, Balestrieri ML, Mauro C, Rizzo MR, Paolisso G, Barbieri M. Non-ST-elevation myocardial infarction outcomes in patients with type 2 diabetes with non-obstructive coronary artery stenosis: effects of incretin treatment. Diabetes Obes Metab. 2018;20:723\u20139.","journal-title":"Diabetes Obes Metab"},{"key":"1492_CR27","doi-asserted-by":"publisher","unstructured":"Preedy MEJ, Baliga RS, Hobbs AJ. Multiplicity of nitric oxide and natriuretic peptide Signalling in heart failure. J Cardiovasc Pharmacol. 2019. https:\/\/doi.org\/10.1097\/FJC.0000000000000724 [Epub ahead of print].","DOI":"10.1097\/FJC.0000000000000724"},{"key":"1492_CR28","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1016\/S0735-1097(02)01967-8","volume":"40","author":"VG Davila-Roman","year":"2002","unstructured":"Davila-Roman VG, Vedala G, Herrero P, de las Fuentes L, Rogers JG, Kelly DP, Gropler RJ. Altered myocardial fatty acid and glucose metabolism in idiopathic dilated cardiomyopathy. J Am Coll Cardiol. 2002;40:271\u20137.","journal-title":"J Am Coll Cardiol"},{"key":"1492_CR29","doi-asserted-by":"publisher","first-page":"2923","DOI":"10.1161\/hc4901.100526","volume":"104","author":"P Razeghi","year":"2001","unstructured":"Razeghi P, Young ME, Alcorn JL, Moravec CS, Frazier OH, Taegtmeyer H. Metabolic gene expression in fetal and failing human heart. Circulation. 2001;104:2923\u201331.","journal-title":"Circulation"},{"key":"1492_CR30","doi-asserted-by":"publisher","first-page":"2837","DOI":"10.1161\/01.CIR.94.11.2837","volume":"94","author":"MN Sack","year":"1996","unstructured":"Sack MN, Rader TA, Park S, Bastin J, McCune SA, Kelly DP. Fatty acid oxidation enzyme gene expression is downregulated in the failing heart. Circulation. 1996;94:2837\u201342.","journal-title":"Circulation"},{"key":"1492_CR31","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1016\/j.cmet.2005.03.002","volume":"1","author":"Z Arany","year":"2005","unstructured":"Arany Z, He H, Lin J, Hoyer K, Handschin C, Toka O, Ahmad F, Matsui T, Chin S, Wu PH, et al. Transcriptional coactivator PGC-1 alpha controls the energy state and contractile function of cardiac muscle. Cell Metab. 2005;1:259\u201371.","journal-title":"Cell Metab"},{"key":"1492_CR32","doi-asserted-by":"publisher","first-page":"H185","DOI":"10.1152\/ajpheart.00081.2008","volume":"295","author":"JJ Lehman","year":"2008","unstructured":"Lehman JJ, Boudina S, Banke NH, Sambandam N, Han X, Young DM, Leone TC, Gross RW, Lewandowski ED, Abel ED, et al. The transcriptional coactivator PGC-1alpha is essential for maximal and efficient cardiac mitochondrial fatty acid oxidation and lipid homeostasis. Am J Physiol Heart Circ Physiol. 2008;295:H185\u201396.","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"1492_CR33","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pbio.0030101","volume":"3","author":"TC Leone","year":"2005","unstructured":"Leone TC, Lehman JJ, Finck BN, Schaeffer PJ, Wende AR, Boudina S, Courtois M, Wozniak DF, Sambandam N, Bernal-Mizrachi C, et al. PGC-1alpha deficiency causes multi-system energy metabolic derangements: muscle dysfunction, abnormal weight control and hepatic steatosis. PLoS Biol. 2005;3:e101.","journal-title":"PLoS Biol"},{"key":"1492_CR34","doi-asserted-by":"publisher","first-page":"1008","DOI":"10.1038\/nature06613","volume":"451","author":"Z Arany","year":"2008","unstructured":"Arany Z, Foo SY, Ma Y, Ruas JL, Bommi-Reddy A, Girnun G, Cooper M, Laznik D, Chinsomboon J, Rangwala SM, et al. HIF-independent regulation of VEGF and angiogenesis by the transcriptional coactivator PGC-1alpha. Nature. 2008;451:1008\u201312.","journal-title":"Nature"},{"key":"1492_CR35","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1161\/CIRCULATIONAHA.114.009625","volume":"131","author":"SF Mohammed","year":"2015","unstructured":"Mohammed SF, Hussain S, Mirzoyev SA, Edwards WD, Maleszewski JJ, Redfield MM. Coronary microvascular rarefaction and myocardial fibrosis in heart failure with preserved ejection fraction. Circulation. 2015;131:550\u20139.","journal-title":"Circulation"},{"key":"1492_CR36","doi-asserted-by":"publisher","first-page":"44732","DOI":"10.18632\/oncotarget.17267","volume":"8","author":"J Garg","year":"2017","unstructured":"Garg J, Feng YX, Jansen SR, Friedrich J, Lezoualc'h F, Schmidt M, Wieland T. Catecholamines facilitate VEGF-dependent angiogenesis via \u03b22-adrenoceptor-induced Epac1 and PKA activation. Oncotarget. 2017;8:44732\u201348.","journal-title":"Oncotarget"},{"key":"1492_CR37","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1111\/nep.13584","volume":"24","author":"E Arif","year":"2019","unstructured":"Arif E, Nihalani D. Beta2-adrenergic receptor in kidney biology: a current prospective. Nephrology (Carlton). 2019;24:497\u2013503.","journal-title":"Nephrology (Carlton)"},{"key":"1492_CR38","doi-asserted-by":"publisher","first-page":"656","DOI":"10.1016\/j.kint.2019.03.023","volume":"96","author":"E Arif","year":"2019","unstructured":"Arif E, Solanki AK, Srivastava P, Rahman B, Fitzgibbon WR, Deng P, Budisavljevic MN, Baicu CF, Zile MR, Megyesi J, Janech MG, Kwon SH, Collier J, Schnellmann RG, Nihalani D. Mitochondrial biogenesis induced by the \u03b22-adrenergic receptor agonist formoterol accelerates podocyte recovery from glomerular injury. Kidney Int. 2019;96:656\u201373.","journal-title":"Kidney Int"}],"container-title":["BMC Cardiovascular Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12872-020-01492-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12872-020-01492-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12872-020-01492-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,6,4]],"date-time":"2021-06-04T23:25:09Z","timestamp":1622849109000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmccardiovascdisord.biomedcentral.com\/articles\/10.1186\/s12872-020-01492-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,6,5]]},"references-count":38,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["1492"],"URL":"https:\/\/doi.org\/10.1186\/s12872-020-01492-3","relation":{},"ISSN":["1471-2261"],"issn-type":[{"value":"1471-2261","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,6,5]]},"assertion":[{"value":"11 June 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 April 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 June 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"All animal experiments were approved by the Institutional Animal Care and Use Committee (IACUC) of Nanjing University, Nanjing, China, and was conducted in accordance with the Guide for the Care and Use of Laboratory Animals from the National Institutes of Health (Bethesda, MD, USA).","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors have declared that no Competing interests exist.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"269"}}